Erythromycin CAS NO.114-07-8

Min.Order Quantity:: 10 Gram

Purity:: 99%

Port:: Wuhan / Shanghai / Guangzhou / Tianjin Port

Payment Terms:: T/T,MoneyGram

Add to Inquiry Cart

Product Details

Keywords

Erythromycin price
Erythromycin supplier
Erythromycin factory

Quick Details

ProName: Erythromycin
CasNo: 114-07-8
Molecular Formula: C37H67NO13
Appearance: white crystalline powder
Application: Pharmaceutical raw intermediates
DeliveryTime: within 5 days after receiving payment
PackAge: as practical needs
Port: Wuhan / Shanghai / Guangzhou ...
ProductionCapacity: 100 Metric Ton/Month
Purity: 99%
Storage: dry and cool place
Transportation: EMS, HKEMS, DHL, TNT, UPS, Fedex....
LimitNum: 10 Gram

Superiority

1. hubei jusheng technology co., ltd., is a global chemical industry manufacturers and suppliers of pharmaceuticals and intermediates in china.

2. the yearly production capacity is 50000mt, 80% for export.we have a professinal export team. both by air and by sea,we ensure that we meet the customer expectations with promptness.
3. our company facing global high-tech pharmaceutical raw materials, high complex new type intermediates, fine chemicals custom synthesis, scale-up production and rare chemicals trade. corey have well-equipped machine, strong technical force and considerate marketing team service.
4. we also have rich experience advantage in basic research, small scale process development, scale-up, industrial technology development & production and cost control.

Details

product name: erythromycin
synonyms: abboticin; abomacetin; dotycin; em; emu; e-mycin; erycin; erycinum
cas: 114-07-8
mf: c37h67no13
mw: 733.93
einecs: 204-040-1
mp: 133-135 ° c
alpha: -74.5 º (c=2, ethanol)
refractive index: -74 ° (c=2, etoh)
storage temp.: 0-6° c
solubility ethanol: soluble
form: powder
chemical properties: white to off white crystalline powder
usage: antibacterial
usage: erythromycin a is a 14-membered macrocyclic lactone with broad spectrum antibiotic activity, isolated from saccharopolyspora erythraea (formerly streptomyces erythreus) in 1952. erythromycin is one of only a handful of microbial metabolites to have profoundly shaped the treatment of bacterial disease in the last 50 years. erythromycin has given rise to new generations of semi-synthetic derivatives with improved stability and potency. our product has been hplc-purified to remove contaminants and degradation products.